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Abstract The distribution of mRNA encoding the inwardly rec- 
tifying K ÷ channel, BIR1 [1] was investigated in rat tissues, and 
a comparison made with the expression of related genes rCKAT e 
and GIRK1 using the reverse transcription-polymerase chain re- 
action (RT-PCR). This showed BIR1 to be expressed in all areas 
of the brain examined, in the eye but not in any other peripheral 
tissue. This pattern was distinct from rCKA~ e and GIRK1. Addi- 
tional in situ hybridisation studies of the central expression of 
BIR1 demonstrated high levels of BIR1 mRNA in the hippocam- 
pus, dentate gyrus, taenia tecta and cerebellum and at lower levels 
in the cortex, habenular nucleus, olfactory bulb, primary olfac- 
tory cortex, thalamus, pontine nucleus and amygdaloid nucleus. 
Key words: Inward rectifier; BIR1; rCKATP; GIRK1; 
Potassium channel; mRNA;  Hybridisation, in situ 
I. Introduction 
A number of members of a gene family have now been 
described that encode inwardly rectifying K ÷ channels [2]. One 
subfamily of these, designated Kir 3.0, encode proteins that, 
when heterologously expressed, give rise to K + channels modu- 
lated by G-protein activation [3-5] and by the presence of 
intracellular ATP [6,7]. A recent addition to this list is a gene 
isolated from a rat insulinoma cell line (RINm5F), known as 
BIR1 [1] which has 72% and 53% identity to rCKAxp and 
G IRK I ,  respectively and is virtually identical (98%) to GIRK2,  
a brain inward rectifier K ÷ channel also modulated by G-pro- 
tein activation [5]. Expression of the BIR 1 sequence in Xenopus 
oocytes demonstrated, under voltage clamp recording, the pres- 
ence of an inwardly rectifying potassium channel. Although the 
nucleotide sequence of BIR1 closely resembles that of rcKAvp 
the expressed protein gives rise to inwardly rectifying potassium 
currents that are not blocked by ATP [1]. Various putative 
regulators in the generation of inward rectifier channels have 
distinct physiological and pharmacological properties [2,8]. Re- 
cent studies also clearly indicate that various members of this 
gene family co-assemble and form functional heteromultimeric 
channels [9-12]. However, it is still unclear how inwardly recti- 
fying K + channels are formed and what relation there is be- 
tween the cloned proteins in vivo. Therefore to elucidate further 
the relationship between these genes we have examined the 
distribution of BIR 1 mRNA in the rat, and compared its distri- 
bution with rcKAv P and GIRK1 mRNAs  using the reverse 
transcription-polymerase chain reaction (RT-PCR). We have 
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also performed a more detailed study of the expression of BIR 1 
in rat brain using in situ hybridisation. 
2. Materials and methods 
2.1. Reverse transcription PCR (RT-PCR) 
Sprague-Dawley rats (8-12 weeks), maintained in a 12 h light~zlark 
cycle with free access to laboratory rodent chow were killed by cervical 
dislocation. Tissues were rapidly dissected out and snap frozen in 
isopentane cooled by solid CO2 and stored at -70°C. Total RNA was 
isolated from samples of rat tissue and the insulin-secreting cell line, 
CRI G1, by acid guanidium thiocyanate/phenot/chloroform extraction 
[13]. Total RNA (10 pg) was reverse transcribed in the presence of an 
anchored oligo(dT)-primer, T~v(A,G,C), using M-MLV reverse tran- 
scriptase (Gibco BRL, Paisley, Renfrewshire, UK) to manufacturers' 
recommendations. PCR primers were synthesised from the BIR1, 
rCKATp and GIRK1 cDNA sequences, (see Table 1 for details). PCR 
primers for fl-actin were used to assess the integrity of RNA samples; 
to guard against false negatives. Primers for sucrase-isomaltase were 
used to ensure specific amplification from RNA, in this case safeguard- 
ing against false positives due to amplification of genomic DNA. All 
primers were synthesised on an Applied Biosystems 394 DNA/RNA 
(Perkin Elmer, Warrington, Cheshire, UK) and all PCR reactions were 
carried out on a Hybaid Omnigene (Hybaid, Teddington, Middlesex, 
UK). Following optimisation of PCR conditions to obtain a single 
band, all products were subjected to a restriction digest in order to 
verify the identity of PCR product. 15 pg of amplified cDNAs were 
digested to completion at 37°C for 1 h with the endonucleases HaelII 
and AluI (Biolabs, New England, USA). Digestion products were then 
separated on a 3.5% MetaPhor agarose gel (FMC BioProducts, Rock- 
land, USA). The same single-stranded cDNA product produced by the 
reverse transcription of total RNAs isolated from each tissue sample 
was used to analyse the expression pattern of these genes. RT product 
equivalent to that produced from 50 ng of total RNA was used for 
subsequent PCR amplification (30 cycles). Each PCR cycle consisted 
of denaturing at 94°C for 45 s, annealing at 64°C with rc-KATp, GIRK1, 
sucrase-isomaltase ndfl-actin primers and 67°C with BIR 1 primers for 
45 s, and extension at 72°C for 1 min. The reaction mixture contained; 
0.5 mM dNTPs, 1.2 U AmpliTaq DNA polymerase (Perkin Elmer), 0.5 
U Perfect Match (Stratagene, Cambridge, Cambs., UK), l x  PCR 
buffer (3.5 mM Mg z+, pH 8.8). PCR products were separated on a 2.5% 
agarose gel (Gibco BRL). 
2.2. In situ hybridisation 
Rat brains were rapidly dissected out and snap frozen in isopentane 
cooled by solid CO2 and stored at -70°C. To assess comprehensively 
the central distribution of BIR 1 mRNA sagittal, horizontal and vertical 
brain sections were cut (10 pm) encompassing most major regions. 
Cryostat sections were thaw-mounted onto (poly)-L-lysine-coated 
slides, fixed in 4% formaldehyde and stored in 95% ethanol at 4°C. The 
basic method used for in situ hybridisation has been described previ- 
ously [14]. Briefly, sense and anti-sense oligodeoxyribonucleotide 
probes complementary to the rat BIR1 channel were synthesised; the 
sequence of the anti-sense probe (5'-GTC AGG ACT GGT GTG AAC 
CGG TAA CCC CAC AGG ATC TCA CTG GTG-3' nucleotides 
984-928) was unique to the rat BIR1 sequence when examined against 
all known rodent sequences. Both sense and anti-sense probes were 
labelled with ~[35S]dATP (>1000 Ci/mmol, Amersham Int. plc, Amer- 
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sham, Bucks., UK) using terminal deoxynucleotidyl transferase (Phar- 
macia, Milton Keynes, Bucks., UK) at 32°C for 1 h. Labelled probe 
was applied to sections in hybridisation buffer containing 4 x standard 
sodium citrate (SSC) and 50% deionised formamide. The slides were 
incubated overnight at 42°C before being washed in 1 x SSC containing 
0.1% sodium thiosulphate for 1 h at 55°C and dehydrated through 
alcohol. Slides were exposed to X-ray film (Kodak, Biomax, Rochester, 
NY, USA) for 7 days, dipped in Ilford K5 emulsion (Amersham), and 
stored desiccated at 4°C for 2 weeks. After development, brain sections 
were stained with hematoxylin and eosin and mounted with a coverslip. 
2.3. Northern blot 
Poly(A) ÷ RNA was selected using a Fast Track mRNA isolation kit 
(Invitrogen, San Diego, USA), separated by electrophoresis ona 1.2% 
formaldehyde agarose gel prior to transfer onto Hybond-N membrane 
(Amersham). RNA was fixed to the membrane by UV irradiation and 
molecular mass markers were made visible by ethidium bromide stain- 
ing. After prehybridisation at 42°C for 1 h, the blot was hybridised at 
42°C for 2 h with the anti-sense probe, end labelled with [32p]dATP 
(6000 Ci/mmol; Amersham) using terminal deoxynucleotidyl trans- 
ferase (Pharmacia), in QuikHyb hybridisation buffer (Stratagene). 
After washing in 1 x SSC/0.1% sodium dodecyl sulphate at room tem- 
perature for 30 min and then at 55°C for 30 rain, the blot was wrapped 
in Saran wrap and exposed for 2 weeks to Fuji RX X-ray film (Genetic 
Research, Felsted, Essex, UK) at - 70°C in a X-ray cassette containing 
intensifying screens. 
3. Results 
RT-PCR has been used to investigate the expression of the 
recently cloned inwardly rectifying K + channel BIR1 in rat 
tissues, and compared with the related genes rCKAT P and 
GIRK1.  To ensure reproducibil ity and the physiological rele- 
vance of this work several precautionary steps were included. 
Firstly, all PCR amplifications have been carried out on the 
same cDNA samples; total RNA samples having been reversed 
transcribed using an anchored oligo(dT)-primer. Secondly, am- 
plification offl-actin cDNA confirmed the integrity of the RNA 
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Fig. 2. Relative abundance of BIR1 mRNA. RT-PCR was performed 
on cDNA products and the PCR reaction mix sampled following 24, 
26, 28 and 30 cycles of amplification and separated on a 2.5% agarose 
gel. Results suggest hat expression in the central nervous ystem is 
highest in the hippocampus, cerebellum and thalamus. 
and its subsequent reverse transcription for each tissue sample, 
guarding against false negatives. Finally, PCR amplification 
using sucrase-isomaltase primers was performed on all cDNA 
samples to ensure that the samples were not contaminated with 
genomic DNA and that the PCR conditions were not over- 
sensitive. Sucrase-isomaltase expression is restricted to the epi- 
thelium of the small intestine [15] and therefore no amplifica- 
tion product should be observed in other tissues, safeguarding 
against false positives. 
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Fig. 1. Tissue distribution of the BIR1, rCKAT P and GIRK1 mRNAs as examined by RT-PCR. Total RNA extracted from a range of rat tissues and 
insulinoma cell line, CRI GI, was reverse transcribed in the presence of an anchored oligo(dT) primer and M-MLV. cDNA products were then 
subjected to 30 cycles of PCR amplification using forward and reverse primers pecific to each cDNA sequence. Amplification offl-actin and sucrase 
isomaltase cDNA serve as controls. PCR products were separated on a 2.5% agarose gel. 
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Fig. 3. Expression of BIR1 in the rat brain. (1) Northern blot analysis of the anti-sense oligonucleotide probe complementary to BIR1 mRNA. 
Hybridisation to poly(A) + RNA (10/ag) extracted from whole rat brain demonstrated the probe to bind to RNA of 1.4 kb. X-Ray autoradiographs 
of horizontal (2), sagittal (3) and vertical (4) sections of rat brain after hybridisation fthe BIRI anti-sense probe. Brain areas howing specific labelling 
are indicated: AM, amygdaloid nucleus; CB, cerebellum; CT, cortex; DG, dentate gyrus; HIP, hippocampus; OB, olfactory bulb; PO, primary 
olfactory cortex: PN, pontine nucleus; TH, thalamus; TT, taenia tecta, HB, habenular nucleus. Scale bar=0.5 cm. 
Following optimisation of the reaction conditions all primer 
pairs gave a single cDNA band of the expected size. A restric- 
tion digest of the cDNA product verified that the RT-PCR had 
amplified specifically the mRNAs of interest (data not shown). 
RT-PCR was then carried out on a range of rat tissues and rat 
insulinoma cells, CRI G1, similar to the cells from which the 
BIR1 was recently cloned [1] (Fig. 1). 
BIRI expression was found throughout the brain; strong 
amplification occurring from the cortex, olfactory bulb, hip- 
pocampus, hypothalamus, thalamus and cerebellum cDNAs, 
whilst moderate l vels of PCR product were obtained from the 
amygdaloid nucleus, striatum and the nucleus accumbens. 
Amongst he peripheral tissues, BIR1 expression could only be 
detected in the eye. However, as predicted CRI G1 cell cDNA 
also gave a signal by RT-PCR (Fig. 1). Use of both forward 
primers with the reverse primer gave identical results (data not 
shown). 
To investigate more closely the distribution of BIRI mRNA 
in areas where PCR products appeared after 30 cycles of ampli- 
fication, further RT-PCR studies were carried out. In these 
studies, samples were taken out and analysed following 24 
cycles of amplification and then following every subsequent 
two rounds of amplification (Fig. 2). cDNAs from the heart, 
skin and skeletal muscle served as negative controls. Since the 
appearance of the RT-PCR product is proportional to the 
amount of BIR1 mRNA present in the initial sample (data not 
shown), these results suggest hat expression in the brain is 
highest in the hippocampus, cerebellum and thalamus: a visible 
band appearing from cDNAs from these regions after 24 cycles. 
After 26 cycles, PCR products could be detected from cDNAs 
of the cortex, olfactory bulb, nucleus accumbens, hypothala- 
mus and CRI G1 cell line. Appearance of PCR product from 
the amygdaloid nucleus and striatum, and then eye cDNAs 
followed after 28 and 30 PCR cycles, respectively. No PCR 
Table l 
PCR primers used for the amplification of specific DNA products from reverse transcribed total RNA 
Gene Accession Nucleotides Primer Sequence 
number 
BIRI X83583 5' untranslated Forward 
9-28 Forward 
258-239 Reverse 
rCKAT P X83584 994-1014 Forward 
1166-114 Reverse 
GIRK 1 L25264 1174-1192 Forward 
1395-1378 Reverse 
fl-Actin V0 l 217 2508-2527 Forward 
3127-3110 Reverse 
Sucrase-isomaltase X15546 1167-1185 Forward 
1370-1351 Reverse 
5'-GTT CCA AGA GAG GCG ATG AGG-3' 
5'-GGC CAA GTT AAC TGA ATC CA-3' 
5'-CAG GGT GGT GAA GAT GTC CG-3' 
5'-CGA TTC ACA CCA GTC CTC ACC-3' 
5'-CAG CCC CCA AGC AAA GGA-3' 
5'-GCA CCA GCC ATA ACC AAC-3' 
5'-TTG CCA GGA ACC GAA CTT-3' 
5'-GAG CTA TGA GCT GCC TGA CG-3' 
5'-CAT TTG CGG TGC ACG ATG-3' 
5'-GGG GAA GTG GAA CAC ACG G-3' 
5'-AGC AGG AGT TGG CTG GAA TG-3' 
All primers were synthesised on an Applied Biosystems 394 DNA/RNA synthesiser. 
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Fig. 4. Cellular expression of BIR1. Bright-field photomicrographs of ections of rat brain showing high densities of silver grains in the pyramidal 
cells of the taenia tecta (a), pyramidal cells of the CA3 region of the hippocampus (b), the granular layer of the cerebellum (c) and granular cell layer 
of the dentate gyrus (d): TT, taenia tecta; CA3, CA3 region of the hippocampus; ML, molecular cell layer; PK, Purkinje cell layer; GL, granular 
layer of the cerebellum; DG, dentate gyrus. Scale bar = 200/IM. 
product was visible from heart, skin and skeletal muscle follow- 
ing 34 cycles of amplification (data not shown). 
Compared to the expression of BIR1, the tissue distribution 
of rCKAvp mRNA was markedly different. Central expression 
of rCKAT v was found to be prevalent in the hypothalamus and 
thalamus with only weak amplification detected from the 
cDNAs of other brain areas. As expected the highest level of 
amplification in peripheral tissues was detected from heart 
cDNA, and in addition, relatively strong expression was also 
detected in the eye and skeletal muscle. Low levels of amplifica- 
tion could be detected in the lung, uterus, bladder and CRI G1 
cell cDNA whilst very little or no PCR product was obtained 
from spleen, stomach, jejunum, proximal colon, kidney, liver, 
testis and skin cDNA (Fig. 1). Furthermore, expression of 
GIRK1 was distinct from that of both BIR1 and rcKAvr (Fig. 
1). High levels of GIRK1 amplification were observed from 
cDNAs of all areas of the brain and in many of the peripheral 
tissues: heart, lung, uterus, testis, eye, skeletal muscle and CRI 
G1 cells. Moderate levels of amplification were observed in all 
other peripheral tissues cDNAs, except for spleen cDNA from 
which no amplification was detected. 
In situ hybridisation histochemistry was employed to eluci- 
date the cellular localisation of BIR 1 expression i  the rat brain 
and confirm central distribution patterns observed from RT- 
PCR studies. Northern blot analysis of poly(A) ÷ RNA from 
whole rat brain was used to confirm the specificity of the anti- 
sense oligonucleotide probe, which hybridized to a single RNA 
band corresponding to the expected size of, 1.4 kb (Fig. 3.1). 
In situ hybridisation of the 35S-labelled oligonucleotide probe 
BIR1 mRNA was then carried out on vertical, sagittal and 
horizontal sections of rat brain (Fig. 4). Hybridisation to BIR 1 
mRNA was greatest in the hippocampus, dentate gyrus, cere- 
bellum and the taenia tecta (the anterior udiment of the hip- 
pocampus). In addition, these studies revealed marked expres- 
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sion of BIR 1 in the cortex, the habenular nucleus, the olfactory 
bulb, the primary olfactory cortex, the thalamus, the pontine 
nucleus and the amygdaloid nucleus (Fig. 3). Under identical 
conditions, no specific hybridisation of the sense oligonucleo- 
tide probe was observed (Fig. 3: 2d, 3d, 4f). To gain further 
insight into the cellular localisation of BIR1 expression, sec- 
tions were dipped in photographic emulsion and subjected to 
microscopic examination. This demonstrated that all pyramidal 
cells of the taenia tecta (the anterior hippocampal rudiment) 
and of the CA1, CA2 and CA3 field of Ammon's horn in the 
hippocampus are strongly labelled (example of specific la- 
belling, Fig. 4a and b). Within the cerebellum the medium-sized 
granule cells exhibit moderate levels of expression, specific hy- 
bridisation was not detected in Purkinje cells or the cells of the 
molecular layer (Fig. 4c). High expression was also observed 
in the granule cells of the dentate gyrus (Fig. 4.d). Moderate 
levels of expression were also observed in the ventral tegmental 
area and the pars compacta region of the substantia nigra (the 
pars reticulata displayed little expression). This is in agreement 
with BIR 1 being expressed in the dopaminergic cells of the pars 
compacta region of the substantia nigra (Henderson, G., per- 
sonal communication). In regions where BIR1 is expressed at 
lower levels, e.g. cortex, the signal appeared to be generalised 
and not restricted to sub-populations of cells within these re- 
gions. Analysis of dipped brain sections revealed no detectable 
cellular expression of BIR1 mRNA in the striatum, possibly 
reflecting the limited sensitivity of this technique in comparison 
to RT-PCR. 
4. Discussion 
We describe herein the tissue and cellular localisation of 
mRNA expression of the inward rectifier K + channel BIR1. 
The strong expression of BIR1 in many brain areas, the eye and 
the insulin secreting cell line CRI-G1, but not in any other 
peripheral tissue agrees with the original findings [1]. The distri- 
bution pattern of rCKAx P from our RT-PCR tissue studies ex- 
tends the observations of and is in general agreement with the 
published data [6] with the exception that we find a strong 
signal from skeletal muscle for rCKAT P. The distribution pattern 
of GIRK1 however shows differences to that previously pub- 
lished. For example in situ hybridisation studies have demon- 
strated abundant expression of GIRK1 (KGA) in rat brain but 
no signal in lung, skeletal muscle or kidney [16]. Our RT-PCR 
data indicate that GIRK1 is widespread in rat brain in agree- 
ment with the former findings, but that the peripheral tissues 
examined including lung, skeletal muscle and kidney also dis- 
play expression of this gene although in many cases at much 
lower levels. Analysis of BIR1 mRNA distribution i  rat brain 
by in situ hybridisation revealed it to be present in many brain 
regions, and is particularly abundant in the granule cell layer 
of the dentate gyrus, all pyramidal cells in the CA1, CA2 and 
CA3 fields of Ammon's horn in the hippocampus, olfactory 
bulb, taenia tecta and the granule cell layer of the cerebellum. 
Thus there is a remarkable similarity in the distribution of BIR 1 
mRNA to that of GIRK1 mRNA in the central nervous ystem 
[16]. Clearly the widespread i entity of distribution pattern for 
these inward rectifier sequences in rat brain suggests that they 
may also be linked functionally. Support for this comes from 
co-expression studies of cloned inward rectifier sequences. Re- 
cently BIR1 [11] and GIRK2 [10] have been shown to co- 
assemble with GIRK1 and produce large G-protein-sensitive, 
inwardly rectifying potassium currents when expressed in Xen- 
opus oocytes. In addition CIR, a protein identical to rCKAT P, 
has also been shown to co-assemble with GIRK1 and enhance 
functional expression of G-protein gated currents [9]. Therefore 
heteropolymerization between GIRK1 and BIRI/GIRK2 or 
rCKAvp/CIR may account for at least some of the diversity of 
inward rectifier K + conductance's under transmitter/G-protein 
control described in central neurones. One surprising finding 
is the presence of GIRK1 mRNA in the CRI-G1 insulin-secret- 
ing cell line. Electrophysiological studies indicate no evidence 
for a muscarinic receptor-regulated G-protein sensitive inward 
rectifier in insulin secreting cells. However, GIRK1 may be a 
subunit of some other G-protein and transmitter regulated K + 
channel in insulin secreting cells [17]. 
The relation is between BIR1 and KATp channels is unclear. 
rCKAx l, has been proposed as the cardiac KAX P channel, or 
subunit hereof [6] and also as a component (CIR) of the en- 
dogenous muscarinic receptor linked G-protein-gated inward 
rectifier of cardiac atrial tissue [12]. The strong homology of 
BIRI to rCKAx P might indicate some similarity of function, 
however, expression studies of BIRI mRNA in Xenopus 
oocytes and single channel analysis indicates that the currents 
induced o not behave as ATP-sensitive channels [1]. However, 
as outlined above evidence is rapidly accumulating that these 
proteins can heterpolymerize and form functional channels, 
and it is possible that BIR 1 and rCKAvp are components of the 
complex currently described as the KAVp channel. Therefore, 
one explanation is that there are heterologous subunits present 
in various cell types which can polymerize or associate as sub- 
units of these inward rectifiers and in so doing modify the 
physiological nd pharmacological properties of the channel. 
Our demonstration that BIR1 is co-expressed in all areas of the 
CNS expressing GIRK1, suggests that such co-assembly is pos- 
sible. One obvious candidate for a modifying subunit is the 
sulphonylurea receptor, recently cloned from rat pancreatic 
fl-cells [18]. At present there are no reports of successful endow- 
ment of inward rectifier cloned sequences with glibenclamide 
sensitivity following co-expression of the sulphonylurea recep- 
tor in Xenopus oocytes. Consequently, either the inward rectifi- 
ers cloned so far bear no relation to the endogenous KAy P 
channels or there are other heterologous subunits still to be 
identified. These data demonstrate a unique pattern of BIRI 
expression in the rat, compared with related sequences, and 
shed light on possible interactions between the potassium chan- 
nel subunits. 
Acknowledgements: T.C.F. is funded by the Wellcome Trust and 
A.K.D. is an BBSRC funded research student. M.L.J.A. supported by 
the Wellcome Trust (Grant 042726). 
References 
[1] Bond, C.T., ,~mm~il~t, C., Ashfield, R., Blair, T.A., Gribble, F., 
Khan, R.N., Lee, K., Proks, P., Rowe, I.C.M., Sakura, H., 
Ashford, M.L.J., Adelman, J.P. and Ashcroft, F.M. (1995). FEBS 
Lett. 367, 61-66. 
[2] Doupnik, C.A., Davidson, N. and Lester, H.A. (1995) Curr. Opin. 
Neurobiol. 5, 268 277. 
[3] Dascal, N., Schreibmayer, W., Lira, N.F., Wang, W., Chavkin, C., 
Dimagno, L., Labarca, C., Keiffer, B.L., Gaveriaux-Ruff, C., 
Trollinger, D., Lester, H.A. and Davidson, N. (1993) Proc. Natl. 
Acad. Sci. USA 90, 10235-10239. 
140 A.K. Dixon et al. IFEBS Letters 374 (1995) 135-140 
[4] Kubo, Y., Reuveny, E., Slesinger, P.A., Jan, Y.N. and Jan, L.Y. 
(1993) Nature 364, 802-806. 
[5] Lesage, F., Duprat, F., Fink, M., Guillemare, E., Coppola, T., 
Lazdunski, M and Hugnot, J.-P. (1994) FEBS Lett. 353, 3742. 
[6] Ashford, M.L.J., Bond, C.T., Blair, T.A. and Adelman, J.E 
(1994). Nature 370, 456459 
[7] Inagaki, N., Tsuura, Y., Namba, N., Masuda, K., Gonoi, T., 
Horie, M., Seino, Y., Mizuta, M. and Seino, S. (1995) J. Biol. 
Chem. 270, 5691 5694. 
[8] Edwards, G. and Weston, A.H. (1993) Annu. Rev. Pharmacol. 
Toxicol. 33, 597~37. 
[9] Kofuji, E, Davidson, N. and Lester H.A. (1995) Proc. Natl. Acad. 
Sci. USA 92, 6542-6546. 
[10] Krapivinski, G., Gordon, E., Wickman, K.D., Velimirovic, B., 
Krapivinsky, L. and Clapham, D.E. (1995) Nature 374, 135 
141. 
[11] Nichols, C.G., Ferrer, J., Pearson, W., Makhina, E. and Permutt, 
A. (1995) J. Physiol. (in press). 
[12] Robertson, S.J., Woodward, R., McKenna, F., Rowe, I.C.M., 
Ashford, M.L.J. and Murrell-Lagnado, R.D. (1995) J. Physiol. (in 
press). 
[13] Chirgwin, J. M., Przybyla, A.E., Macdonald, R.L. and Ruttler, 
W.J. (1979) Biochemistry 18, 5294-5299. 
[14] Sirinathsinghji, D.J.S. and Dunnett, S.B. (1991) in: Molecular Im- 
aging in Neuroscience: a Practical Approach (N.A. Sharif ed.) 
pp. 43-70, IRL press at Oxford University Press, Oxford. 
[15] Charandrasena, G. Sunitha, I., Lau, C., Nanthakumar, N.N. and 
Henning, S.J. (1992) Cell. Mol. Biol. 38, 243 254. 
[16] Karschin, C., Schreibmayer, W., Dascal, N., Lester, H., Davidson, 
N. and Karschin, A. (1994) FEBS Lett. 348, 139-144. 
[17] Dunne, M.J. (1992) in: Potassium Channel Modulators (Weston, 
A.H. and Hamilton, T.C. eds.) pp. 11(~143, Blackwell Scientific 
Publications. 
[18] Aguilar-Bryan, L., Nichols, C.G., Wechsler, S.W., Clement, J.P., 
Boyd, A.E., Gonzalez, G., Herrera-Sosa, H., Nguy, K., Bryan, J. 
and Nelson, D.A. (1995) Science 268, 423426. 
